DAN 5708 Pill — GRAY;PINK CAPSULE, 19mm — Clindamycin

No photo available
View full Clindamycin profile
ImprintDAN / 5708
ColourGRAY;PINK
ShapeCAPSULE
Size19
StrengthCLINDAMYCIN HYDROCHLORIDE 150 mg
Dosage formCapsule
ManufacturerSt. Mary's Medical Park Pharmacy
NDC60760-570
Schedule—
Availability—
IngredientsCLINDAMYCIN HYDROCHLORIDE[CLINDAMYCIN]

What does this imprint mean?

The imprint "DAN 5708" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Clindamycin

Uses and warnings

Boxed Warning: Clostridium difficile-associated diarrhea (CDAD) ranging from mild diarrhea to fatal colitis has been reported. The drug alters normal colon flora, risking C. difficile overgrowth. "CDAD must be considered in all patients who present with diarrhea following antibiotic use," even occurring over two months after therapy ends. Additional warnings include severe skin reactions (including fatal cases), contraindication in meningitis (inadequate CSF penetration), and caution in patients with gastrointestinal disease or hepatic/renal impairment.

Clindamycin treats serious infections caused by susceptible bacteria, including anaerobes, streptococci, pneumococci, and staphylococci. Use should be reserved for penicillin-allergic patients or when penicillin is inappropriate. Specific indications include respiratory tract infections, skin and soft tissue infections, septicemia, intra-abdominal infections, and pelvic/genital infections. "Bacteriologic studies should be performed to determine the causative organisms and their susceptibility."

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Clindamycin

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 7a7f2f56-a654-fd89-e053-2a91aa0a4680.xml